Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
Federal Reserve Vice Chair Richard Clarida said Friday the global economy has deteriorated in the past month.Marketsread more
The latest escalation in the trade war ups the odds the economy will fall into recession and that the Fed will aggressively cut rates.Market Insiderread more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
"We don't need China and, frankly, would be far better off without them," Trump tweeted.Politicsread more
"My only question is, who is our bigger enemy, Jay Powell or Chairman Xi?" Trump wrote amid a series of tweets that rattled markets Friday.Politicsread more
The death comes as federal and state health officials investigate a slew of lung illnesses in connection to e-cigarette use.Health and Scienceread more
Supreme Court Justice Ruth Bader Ginsburg has completed a three-week course of radiation therapy for cancer, the top court said in a statement Friday.Politicsread more
Epstein, a former friend of Presidents Donald Trump and Bill Clinton, was arrested by FBI agents in New Jersey in early July as he stepped off his private plane, which had...Politicsread more
Lowe's is vying for a category of customer that Home Depot has traditionally dominated — the professional contractor.Retailread more
The president tweeted Friday morning that he was ordering "our great American companies" to "immediately start looking for an alternative to China."Marketsread more
Aug 7 (Reuters) - CVS Health Corp on Wednesday reported a profit for the second quarter compared with a year-ago loss, benefiting from its Aetna health insurance acquisition and higher sales of prescription drugs.
The company reported net income of $1.94 billion, or $1.49 per share, for the second quarter ended June 30, compared with a loss of $2.56 billion, or $2.52 per share, a year earlier.
CVS had taken a $3.9 billion goodwill impairment charge related to its Omnicare business in the second quarter of 2018.
Revenue rose 35.2% to $63.43 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)